UK AI health rules could give firms ‘competitive edge’ as ministers back overhaul
Experts have said Britain’s new approach to regulating AI in healthcare could give UK tech firms a “competitive edge” by letting them prove their technology in the NHS earlier. The UK government on Tuesday accepted all 44 recommendations of the National Commission into the Regulation of AI in Healthcare, paving the way for a shake-up [...]
The UK government has approved all 44 suggestions from a National Commission aimed at reshaping how artificial intelligence is regulated in healthcare. This move is expected to give British technology firms a competitive advantage by allowing them to test and refine their AI-powered medical devices within the NHS sooner. The Medicines and Healthcare products Regulatory Agency (MHRA) will shift its focus from a single pre-market assessment to ongoing monitoring of AI devices throughout their lifecycles.
This new approach could lower entry barriers for health tech companies and make the UK a more attractive destination for investors, but the potential benefits hinge on the NHS's willingness to purchase the technology. The overhaul aims to strike a balance between fostering safe and innovative healthcare solutions and maintaining manageable regulatory requirements.
However, the government and MHRA must ensure the UK's regulatory framework remains compatible with international standards to prevent overseas barriers to market expansion. Health minister James Frith emphasized that while AI innovation must be expedited, it must not compromise patient safety.
Written by urgent.news from City AM's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
